Barry E Greene's Net Worth

$67.4 Million

Estimate Recalculated Nov 7, 2024 05:13PM EST

Who is Barry E Greene

Barry E Greene has an estimated net worth of $67.4 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., Karyopharm Therapeutics Inc., BCLS Acquisition Corp., Sage Therapeutics, Inc., ACORDA THERAPEUTICS INC, and Regulus Therapeutics Inc..

SEC CIK

Barry E Greene's CIK is 0001291963

Past Insider Trading and Trends

2020 was Barry E Greene's most active year for acquiring shares with 14 total transactions. Barry E Greene's most active month to acquire stocks was the month of July. 2007 was Barry E Greene's most active year for disposing of shares, totalling 78 transactions. Barry E Greene's most active month to dispose stocks was the month of September. 2017 saw Barry E Greene paying a total of $4,624,862.35 for 266,840 shares, this is the most they've acquired in one year. In 2017 Barry E Greene cashed out on 363,586 shares for a total of $18,636,185.80, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALNYLAM PHARMACEUTICALS, INC.

President
Updated Sep 11, 2020
Form 4
-24.74%
-44.69K
$66.19
-$5.08M
Sep 11, 2020
138.91K
Sale
ScheduledJul 16 - Sep 09
Form 4
$70.95
$349.87K
Aug 11, 2020
271.35K
Options
Aug 10
Form 4
-17.26%
-22.27K
$84.57
-$3.36M
Jul 09, 2020
113.26K
Sale
ScheduledJul 07
Form 4
-14.72%
-22.27K
$79.57
-$3.14M
May 07, 2020
135.52K
Sale
ScheduledMay 06
Form 4
6.42%
3.75K
$104.82
-$174.32K
Apr 09, 2020
68.73K
Grant
Apr 07
Form 4
29.93K
Feb 28, 2020
29.93K
Grant
Feb 26
Form 4
100.00%
10.00K
Dec 26, 2019
20.00K
Grant
Dec 23
Form 4
10.00K
Nov 26, 2019
10.00K
Grant
Nov 22
Form 4
-48.74%
-58.91K
$53.21
-$4.33M
Oct 24, 2019
64.97K
Sale
ScheduledOct 22 - Oct 23
Form 4
31.52%
16.30K
$88.95
$889.50K
Aug 07, 2019
129.97K
Acquisition
Jul 11 - Aug 06
Form 4
41.10%
6.32K
Jun 07, 2019
83.68K
Acquisition
Oct 18 - Jun 05
Form 4
32.50K
Mar 01, 2019
32.50K
Grant
Feb 28
Form 4
61.90%
16.25K
Sep 28, 2018
42.50K
Grant
Sep 27
Form 4
100.00%
10.00K
Aug 23, 2018
20.00K
Grant
Aug 21
Form 4
24.46%
30.95K
Aug 14, 2018
157.48K
Acquisition
Jan 17 - Aug 10
Form 4
-38.30%
-38.46K
$143.10
-$5.50M
Mar 16, 2018
64.78K
Sale
ScheduledMar 14
Form 4
30.00K
Mar 05, 2018
30.00K
Grant
Mar 01
Form 4
6.25K
Dec 21, 2017
6.25K
Grant
Dec 20
Form 4
10.00K
Nov 08, 2017
10.00K
Grant
Nov 06
Form 4
-45.93%
-85.32K
$73.18
-$8.84M
Oct 04, 2017
103.24K
Sale
ScheduledOct 02
Form 4
-17.28%
-61.81K
$64.42
-$5.12M
Sep 22, 2017
298.79K
Sale
ScheduledSep 20 - Sep 21
Form 4
100.00%
15.88K
Jul 11, 2017
31.75K
Grant
Jul 07
Form 4
25.00K
Dec 22, 2016
25.00K
Grant
Dec 20
Form 4
-26.43%
-31.82K
$32.87
-$103.11K
Dec 05, 2016
91.30K
Sale
ScheduledDec 01
Form 4
$8.20
$135.67K
Mar 28, 2016
248.89K
Options
Mar 24
Form 4
15.88K
Feb 03, 2016
15.88K
Grant
Feb 01
Form 4
75.25%
37.90K
Dec 22, 2015
90.89K
Grant
Nov 18 - Dec 18
Form 4
$18.73
$505.12K
Aug 06, 2015
372.02K
Options
Aug 04
Form 4
-69.18%
-67.38K
$69.06
-$7.54M
May 28, 2015
32.60K
Sale
ScheduledMay 26
Form 4
47.63K
May 05, 2015
73.61K
Grant
May 01
Form 4
-10.31%
-11.20K
$56.56
-$1.11M
Dec 22, 2014
99.96K
Sale
ScheduledDec 19 - Dec 22
Form 4
15.00K
Dec 16, 2014
15.00K
Grant
Dec 12
Form 4
-49.71%
-33.20K
$48.21
-$2.75M
Nov 19, 2014
36.16K
Sale
ScheduledNov 17
Form 4
-14.25%
-11.10K
$53.39
-$1.03M
Nov 13, 2014
69.36K
Sale
ScheduledNov 11
Form 4
-2.11%
-1.68K
$42.73
$27.60
Feb 04, 2014
80.38K
Options
Feb 03
Form 4
141.58%
90.00K
$6.78
$75.94K
Dec 18, 2013
156.06K
Options
Dec 17 - Dec 18
Form 4
10.00K
Oct 22, 2013
10.00K
Grant
Oct 21
Form 4
-83.31%
-22.82K
$15.48
-$662.98K
May 30, 2013
6.98K
Sale
ScheduledMay 28
Form 4
-84.03%
-24.06K
$12.98
-$578.59K
Mar 18, 2013
6.88K
Sale
ScheduledMar 14
Form 4
-45.60%
-24.00K
$12.69
-$563.47K
Mar 11, 2013
30.94K
Sale
ScheduledMar 08
Form 4
100.00K
Dec 21, 2012
100.00K
Grant
Dec 20
Form 4
68.58%
1.86K
$10.75
$20.00K
Feb 23, 2012
6.42K
Purchase
Feb 21
Form 4
26.43%
567.00
$8.80
$4.99K
Jan 11, 2012
4.56K
Purchase
ScheduledJan 09
Form 4
48.34%
699.00
$7.15
$5.00K
Dec 14, 2011
3.99K
Purchase
ScheduledDec 12
Form 4
100.00K
Dec 02, 2011
100.00K
Grant
Nov 30
Form 4
94.88%
704.00
$7.09
$4.99K
Nov 16, 2011
3.30K
Purchase
ScheduledNov 14
Form 4
742.00
$6.73
$5.00K
Oct 13, 2011
2.59K
Purchase
ScheduledOct 11
Form 4
100.00K
Dec 10, 2010
101.30K
Grant
Dec 08
Form 4
65.00K
Dec 11, 2009
65.98K
Grant
Dec 10
Form 4
90.00K
Dec 11, 2008
90.00K
Grant
Dec 09
Form 4
-42.44%
-35.44K
$17.45
-$1.17M
Aug 15, 2008
48.78K
Sale
ScheduledAug 13
Form 4
80.00K
Dec 14, 2007
80.00K
Grant
Dec 12
Form 4
-53.42%
-5.22K
$31.63
-$165.13K
Oct 26, 2007
4.55K
Sale
ScheduledOct 24
Form 4
-51.99%
-10.58K
$31.13
-$329.37K
Oct 26, 2007
9.77K
Sale
ScheduledOct 24
Form 4
-51.60%
-21.70K
$30.85
-$669.36K
Oct 26, 2007
20.35K
Sale
ScheduledOct 24
Form 4
60.00K
Dec 15, 2006
60.00K
Grant
Dec 14
Form 4
-22.91%
-12.50K
$20.71
-$258.87K
Nov 01, 2006
42.05K
Sale
ScheduledOct 31
Form 4
75.00K
Dec 09, 2005
75.00K
Grant
Dec 07
Form 4
75.00K
Dec 09, 2004
75.00K
Grant
Dec 07
Form 4
0.89%
480.00
$6.00
$2.88K
Nov 23, 2004
54.55K
Purchase
Nov 19
Form 4
2.74%
1.44K
$4.85
$6.98K
Aug 27, 2004
54.07K
Purchase
Aug 25
Form 3
May 27, 2004
52.63K
Showing 62 results

Karyopharm Therapeutics Inc.

Investor
Updated May 30, 2024
Form 4
69.00K
May 30, 2024
69.00K
Grant
May 29
Form 4
34.00K
May 25, 2023
34.00K
Grant
May 24
Form 4
$1.49
$11.25K
Aug 15, 2022
13.61K
Options
Aug 11
Form 4
23.90K
May 20, 2022
23.90K
Grant
May 19
Form 4
23.90K
May 21, 2021
23.90K
Grant
May 21
Form 4
16.40K
May 26, 2020
16.40K
Grant
May 21
Form 4
$0.03
$99.99
Mar 17, 2020
6.03K
Options
Mar 13
Form 4
25.00K
Jun 07, 2019
25.00K
Grant
Jun 06
Form 4
17.00K
Jun 20, 2018
17.00K
Grant
Jun 19
Form 4
17.00K
Jun 16, 2017
17.00K
Grant
Jun 15
Form 4
10.00K
Jun 17, 2016
10.00K
Grant
Jun 16
Form 4
10.00K
May 26, 2015
10.00K
Grant
May 22
Form 4
3.00K
$29.31
$87.94K
Apr 06, 2015
3.00K
Purchase
Apr 02
Form 4
10.00K
Jul 09, 2014
10.00K
Grant
Jul 08
Form 3
Nov 05, 2013
Showing 15 results

BCLS Acquisition Corp.

Investor
Updated Oct 22, 2020
Form 3
Oct 22, 2020
Showing 1 results

Sage Therapeutics, Inc.

President and CEO
Updated Aug 07, 2024
Form 4
81.22%
38.13K
$8.96
-$109.97K
Aug 07, 2024
85.07K
Grant
Aug 05
Form 4
168.00K
Feb 15, 2024
168.00K
Grant
Feb 13
Form 4
195.00K
Aug 08, 2023
195.00K
Grant
Aug 04
Form 4
66.50K
Feb 15, 2023
66.50K
Grant
Feb 13
Form 4
44.70%
14.50K
$34.48
$500.02K
Nov 15, 2022
46.94K
Purchase
Nov 10
Form 4
69.92K
Feb 15, 2022
69.92K
Grant
Feb 11
Form 4
268.64%
23.64K
$43.15
$1.02M
Aug 09, 2021
32.44K
Purchase
Aug 05
Form 4
8.80K
$56.32
$495.63K
Jun 17, 2021
8.80K
Purchase
Jun 16
Form 4
390.00K
Jan 06, 2021
390.00K
Grant
Jan 04
Form 4
20.00K
Oct 05, 2020
20.00K
Grant
Oct 01
Form 3
Oct 05, 2020
Showing 11 results

ACORDA THERAPEUTICS INC

Investor
Updated Jun 04, 2021
Form 4
10.00K
Jun 04, 2021
10.00K
Grant
Jun 02
Form 4
15.00K
Jun 17, 2020
15.00K
Grant
Jun 15
Form 4
15.00K
Jun 21, 2019
15.00K
Grant
Jun 19
Form 4
15.00K
Jun 29, 2018
15.00K
Grant
Jun 27
Form 4
-87.27%
-8.73K
$21.63
$6.30
May 23, 2018
1.27K
Options
May 21
Form 4
-100.00%
-10.00K
$19.89
-$33.60K
Aug 03, 2017
Sale
ScheduledAug 01
Form 4
15.00K
Jun 02, 2017
15.00K
Grant
May 31
Form 4
-100.00%
-723.00
$22.39
-$375.96
Feb 13, 2017
Sale
ScheduledFeb 09
Form 4
-100.00%
-3.02K
$17.59
-$10.11K
Jan 05, 2017
Sale
ScheduledJan 03
Form 4
15.00K
Jun 10, 2016
15.00K
Grant
Jun 08
Form 4
15.00K
Jun 11, 2015
15.00K
Grant
Jun 09
Form 4
10.00K
Jun 09, 2014
10.00K
Grant
Jun 05
Form 4
10.00K
Jun 03, 2013
10.00K
Grant
May 30
Form 4
10.00K
Jun 07, 2012
10.00K
Grant
Jun 06
Form 4
10.00K
Jun 20, 2011
10.00K
Grant
Jun 16
Form 4
10.00K
Jun 10, 2010
10.00K
Grant
Jun 09
Form 4
10.00K
Jun 23, 2009
10.00K
Grant
Jun 22
Form 4
10.00K
May 23, 2008
10.00K
Grant
May 21
Form 4
10.00K
Aug 07, 2007
10.00K
Grant
Aug 06
Form 4
23.96%
723.00
Feb 16, 2007
3.74K
Grant
Feb 14
Form 4
3.02K
Jan 10, 2007
3.02K
Grant
Jan 09
Form 3
Jan 10, 2007
Showing 22 results

Regulus Therapeutics Inc.

Investor
Updated Nov 07, 2012
Form 4
25.00K
Nov 07, 2012
25.00K
Grant
Nov 05
Form 4
Oct 11, 2012
6.15M
Options
Oct 10
Form 3
Oct 04, 2012
Showing 3 results